Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916 (Q33432475)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916 |
scientific article |
Statements
1 reference
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916 (English)
1 reference
George Wilding
1 reference
Celestia S Higano
1 reference
Eric J Small
1 reference
Maha Hussain
1 reference
Bryan Goldman
1 reference
Cathy Tangen
1 reference
Daniel P Petrylak
1 reference
Atif M Akdas
1 reference
Bryan J Donnelly
1 reference
Subramanian Kanaga Sundram
1 reference
Patrick A Burch
1 reference
Robert S Dipaola
1 reference
E David Crawford
1 reference
20 April 2009
1 reference
1 reference
27
1 reference
15
1 reference
2450-2456
1 reference
Identifiers
1 reference
1 reference
1 reference